CME and NYSE call for Hyperliquid oversight amid DeFi clash
6.6 Regulation CME and NYSE urge U.S. regulators to tighten oversight of Hyperliquid, citing manipulation risks. Hyperliquid defends its transparency, while the crypto community highlights inconsistencies in traditional finance's stance.
CME Group and NYSE, along with Intercontinental Exchange (ICE), are intensifying calls for U.S. regulators to increase oversight of Hyperliquid, a decentralized derivatives platform. Their concerns focus on potential market manipulation, sanctions evasion, and the impact of Hyperliquid’s 24/7, anonymous trading on commodity price discovery, particularly for oil-linked perpetual contracts. Hyperliquid’s rapid growth, high trading volumes, and influence on real-world prices have made it a significant competitor to traditional exchanges. In response, the Hyperliquid Policy Center asserts that its on-chain transparency surpasses that of legacy venues and supports regulatory monitoring, while also highlighting the lack of specific U.S. regulations for on-chain derivatives. The crypto community has criticized the exchanges’ stance, noting ICE’s investment in Polymarket as inconsistent. Following the regulatory push, HYPE, Hyperliquid’s native token, saw a sharp price drop, though potential ETF filings could bring stability. This situation underscores the growing tension between traditional finance and DeFi platforms.
